The trading price of Onconova Therapeutics Inc (NASDAQ:ONTX) floating lower at last check on Tuesday, April 02, closing at $0.92, -8.00% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $1.45 and a 52-week low of $0.55. Over the past month, the stock has gained 10.86% in value.
Onconova Therapeutics Inc, whose market valuation is $19.32 million at the time of this writing, is expected to release its quarterly earnings report May 13, 2024 – May 17, 2024. Investors’ optimism about the company’s current quarter earnings report is understandable.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Onconova Therapeutics Inc No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest ONTX has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 50% Buy.
A quick review shows that ONTX’s price is currently 1.44% off the SMA20 and 16.89% off the SMA50. The RSI metric on the 14-day chart is currently showing 55.68, and weekly volatility stands at 6.97%. When measured over the past 30 days, the indicator reaches 8.27%. Onconova Therapeutics Inc (NASDAQ:ONTX)’s beta value is currently sitting at 1.35, while the Average True Range indicator is currently displaying 0.07.
To see how Onconova Therapeutics Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: ONTX stock’s performance was -8.00% at last check in today’s session, and 22.68% in the past year.
An evaluation of the daily trading volume of Onconova Therapeutics Inc (NASDAQ:ONTX) indicates that the 3-month average is 77.62K. However, this figure has increased over the past 10 days to an average of 97380.0.
Currently, records show that 21.00 million of the company’s shares remain outstanding. The insiders hold 0.78% of outstanding shares, whereas institutions hold 7.94%. The stats also highlight that short interest as of Mar 15, 2024, stood at 20700.0 shares, resulting in a short ratio of 0.19 at that time. From this, we can conclude that short interest is 0.10% of the company’s total outstanding shares. It is noteworthy that short shares in March were down slightly from the previous month’s figure, which was 31060.0. However, since the stock’s price has seen 23.39% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
